Blood transfusion: Difference between revisions
From IDWiki
No edit summary |
(→) |
||
(One intermediate revision by the same user not shown) | |||
Line 32: | Line 32: | ||
== Platelets == |
== Platelets == |
||
+ | * [[Platelet transfusion]] |
||
− | * Caution in prothrombotic thrombocytopenia syndromes like [[HIT]], [[TTP]], and catastrophic [[antiphospholipid syndrome]] |
||
− | * Of limited utility in [[ITP]] |
||
− | |||
− | === Indications === |
||
− | |||
− | * In non-immune thrombocytopenia, it is reasonable to maintain platelets over 10 |
||
− | * For procedures with low risk of blood loss (e.g. appendectomy, cholecystectomy, vaginal delivery) |
||
− | ** Platelets less than 20: transfuse 1 dose |
||
− | ** Platelets 20 to 50: transfuse 1 dose if significant bleeding occurs |
||
− | * For procedures with high risk of blood loss, transfuse 1 dose for platelets less than 50 |
||
− | * For neurosurgery, ophthalmologic procedures, or significant head trauma with high risk of [[intracranial hemorrhage]], maintain platelets above 100 (may need multiple doses) |
||
− | * For bleeding from platelet dysfunction (e.g. post-cardiopulmonary bypass, or congenital platelet defect), transfusion may be required regardless of platelet count |
||
== Plasma == |
== Plasma == |
||
Line 60: | Line 49: | ||
* Not useful when INR less than 1.8, when used 1:1 with RBCs, if there is no pending surgery or bleeding, for the reversal of [[warfarin]], for the reversal of other anticoagulants, or as nutritional support |
* Not useful when INR less than 1.8, when used 1:1 with RBCs, if there is no pending surgery or bleeding, for the reversal of [[warfarin]], for the reversal of other anticoagulants, or as nutritional support |
||
− | == Reactions == |
+ | == Transfusion Reactions == |
{| class="wikitable" |
{| class="wikitable" |
||
!Risk |
!Risk |
||
Line 125: | Line 114: | ||
|Transmission of [[HIV]] |
|Transmission of [[HIV]] |
||
|} |
|} |
||
+ | |||
+ | * Other transmissible infections include: |
||
+ | ** Viruses: [[parvovirus B19]], [[hepatitis A virus]], [[hepatitis E virus]], [[Zika virus]], [[dengue virus]], and [[chikungunya virus]] |
||
+ | ** Protozoa: [[malaria]], [[Chagas disease]], [[toxoplasmosis]], [[leishmaniasis]], [[babesiosis]] |
||
+ | ** Helminths: [[filariasis]] |
||
+ | ** Spirochetes: [[syphilis]], [[Lyme disease]] |
||
+ | ** Rickettsiae: [[Rocky Mountain spotted fever]], [[Coxiella burnetii]], and [[Ehrlichia]] |
||
=== Fever === |
=== Fever === |
Latest revision as of 13:25, 22 October 2024
Red Blood Cells
Group & Screen and Crossmatch
- ABO blood type (O, A, B, or AB)
- Most important antigen group
- RhD group (positive or negative)
- Second most important antigen group
- There are more than 30 minor blood group antigens, including Kell (K and k), Kidd (Jk^a^ and Jk^b^), Duffy (Fy^a^ and Fy^b^) and MNS (S and s)
- Group and screen
- Group tests recipient for ABO and RhD status
- Screen tests the recipient plasma for unexpected and clinically significant minor antigen incompatibility
- Takes about 45 minutes, but if the screen is positive then can take days to determine which specific antibodies are causing the problem
- Crossmatch confirms that a specific unit of RBCs is safe to give to the recipient
- If screen was negative, an abbreviated crossmatch is done either as immediate spin or as electronic
- If screen was positive, then a full antiglobulin crossmatch is done
Basics
- Each unit is about 300 mL with a hematocrit of 65 to 70%, and raises the recipient's hemoglobin by about 10 g/L
- Usually transfused over 2 hours
- Can do up to 3 or 3.5 hours in elderly over 70 years old, heart failure, LV dysfunction, prior MI, renal dysfunction, or volume overload (usually with concurrent diuretics at the start of the transfusion)
Indications
- Acute blood loss
- Maintain hemoglobin above 70 g/L during active bleeding
- Maintain hemoglobin higher (e.g. above 80 g/L) during active bleeding in patients with:
- Unstable or acute coronary syndrome
- Coronary artery disease
- Uncontrolled or unpredictable bleeding
- Anemia
- Consider for hemoglobin below 70 g/L in stable patients
- Consider for hemoglobin below 80 g/L in patients undergoing orthopedic or cardiac surgery or with cardiovascular disease
Platelets
Plasma
- Each unit has a volume of 250 mL and requires 30 minutes to thaw
- It must be ABO compatible
- The usual dose is 10 to 15 mL/kg (3 to 4 units for average human)
- Units are transfused over 30 minutes to 2 hours (maximum 3.5 hours)
- A single dose (10 to 15 mL/kg) should normalize the INR and PTT if within 1.3 to 1.8 times normal, and lasts 6 hours (the half-life of factor VII)
Indications
- Before a procedure or during active bleeding where the INR, PT, or PTT is at least 1.8 times normal, and no other therapies are available
- During massive transfusion protocols (6 to 10 units of RBCs expected within 6 hours)
- Before a procedure or during active bleeding in patients with severe liver disease and INR greater than 2 times normal
- Not useful when INR less than 1.8, when used 1:1 with RBCs, if there is no pending surgery or bleeding, for the reversal of warfarin, for the reversal of other anticoagulants, or as nutritional support
Transfusion Reactions
Risk | Event |
---|---|
1 in 13 | Red cell sensitization, increasing risk of hemolytic transfusion reaction and hemolytic disease of the fetus and newborn |
1 in 20 | Febrile non-hemolytic transfusion reaction, per pool of platelets |
1 in 100 | Transfusion-associated circulatory overload |
1 in 100 | Minor allergic reaction (urticaria) |
1 in 300 | Febrile non-hemolytic transfusion reaction, per unit of RBCs |
1 in 7,000 | Delayed hemolytic transfusion reaction |
1 in 10,000 | Transfusion-related acute lung injury (TRALI) |
1 in 10,000 | Symptomatic bacterial infection, per pool of platelets |
1 in 40,000 | ABO mismatch, per unit of RBCs |
1 in 40,000 | Anaphylaxis |
1 in 100,000 | Post-transfusion purpura |
1 in 200,000 | Death from bacterial infection, per pool of platelets |
1 in 250,000 | Symptomatic bacterial infection, per unit of RBCs |
1 in 500,000 | Death from bacterial infection, per unit of RBCs |
<1 in 1,000,000 | Transmission of West Nile virus |
1 in 4,000,000 | Transmission of Chagas disease |
1 in 7,500,000 | Transmission of hepatitis B virus |
1 in 7,600,000 | Transmission of HTLV |
1 in 13,000,000 | Transmission of hepatitis C virus |
1 in 21,000,000 | Transmission of HIV |
- Other transmissible infections include:
- Viruses: parvovirus B19, hepatitis A virus, hepatitis E virus, Zika virus, dengue virus, and chikungunya virus
- Protozoa: malaria, Chagas disease, toxoplasmosis, leishmaniasis, babesiosis
- Helminths: filariasis
- Spirochetes: syphilis, Lyme disease
- Rickettsiae: Rocky Mountain spotted fever, Coxiella burnetii, and Ehrlichia
Fever
- Differential diagnosis includes bacterial infection, acute hemolytic transfusion reaction, and febrile non-hemolytic transfusion reaction
- Stop transfusion, check vitals, compare patient name to name on blood product
- If severe:
- Collect blood bank samples to recheck ABO group
- Send unit to blood bank for bacterial cultures and compatibility testing
- Send blood cultures
- If mild: give acetaminophen 325 mg and continue transfusion
Dyspnea
- Differential includes transfusion-related acute lung injury, transfusion-associated circulatory overload, and anaphylaxis
- Stop transfusion, check vitals q15min, compare patient name to name on blood product
- Chest x-ray
Allergic Reactions
Minor Allergic Reactions
- Minor reactions may include urticaria, flushing, erythema, pruritis, cough, wheeze, nausea, vomiting, abdominal pain, and diarrhea
- For minor reactions
- Stop the transfusion
- Give diphenhydramine 25 to 50 mg p.o. or IV
- If urticarial rash is less than 2/3 BSA and no other concerning symptoms, restart the transfusion slowly
- For recurrent urticarial reactions, consider premedication with diphenhydramine, cetirizine, and/or steroids
Anaphylaxis
- Anaphylaxis usually starts immediately or up to 45 minutes of starting the transfusion
- Symptoms include:
- Urticaria and flushing are usually present
- May have airway obstruction with dyspnea, chest pain, wheezing, and stridor
- Hypotension
- Nausea and vomiting
- For severe allergic reactions:
- Stop the transfusion and do not restart
- Diphenhydramine 25 to 50 mg IV
- For anaphylaxis, epinephrine and steroids
Cytopenias
- Differential includes transfusion-associated graft-versus-host disease and post-transfusion purpura